Life Sciences: Patent Litigation | Europe

Clifford Chance has a long-established reputation as a market-leading IP practice in Spain. It benefits from the presence both of hugely respected senior partners and of more junior lawyers who also attract roles in important life sciences sector cases. The firm acts for some of the world's most prominent pharmaceutical, biotechnology, medical devices and diagnostics companies on patent infringement actions against competing entities and any corresponding revocation actions. The law firm is increasingly recognised in regulatory work, licence agreements, as well as M&A in the life sciences sector.

Uría Menéndez demonstrates superb coverage of the various regulatory, commercial and intellectual property-related issues arising for companies operating in the life sciences sector. Its lawyers advise on the negotiation of collaboration agreements for the development or manufacture of drugs. The team has experience in applications for authorisation of supply contracts, and it advises on appeals against decisions made on pricing and reimbursement. It assists life sciences companies with questions relating to the legitimate use of health data. Uría Menéndez's civil litigation capabilities are showcased in advice on advertising disputes, product liability cases and patent infringement actions. The firm also possesses notable experience in cases relating to the enforcement of plant variety rights.

Vidal-Quadras & Ramon has a notable reputation for coverage of life sciences disputes. The lawyers are best known for their handling of patent litigation on behalf of generics manufacturers, often assisting with the filing of nullity claims against patent holders. The team also has experience in related cases in which innovators seek to challenge marketing authorisations granted to generics companies.

Bird & Bird has a recognised practice in patent litigation within the life sciences area. The law firm regularly advises clients in relation to patent infringements, as well as filing applications for intervention and damage claims.

HOYNG ROKH MONEGIER's Madrid team forms part of a broader European IP practice that has experience in the coordination of significant life sciences sector patent disputes across multiple jurisdictions. The firm advises on patent infringement and invalidity actions brought by producers of drugs, biosimilar products and medical devices. It also acts for animal health and crop science companies.